Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.
Cancer
PROCEDURE: Biopsy
Number of clinical secondary effects bind to targeted therapies, Dermatological exam including questionnaire, clinical examination and photographies, Every 28 days up to 5 years
The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.